Notch signalling plays a key role in the generation of haematopoietic stem cells (HSCs) during vertebrate development [1] [2] [3] and requires intimate contact between signal-emitting and signal-receiving cells, although little is known regarding when, where and how these intercellular events occur. We previously reported that the somitic Notch ligands, Dlc and Dld, are essential for HSC specification 4 . It has remained unclear, however, how these somitic requirements are connected to the later emergence of HSCs from the dorsal aorta. Here we show in zebrafish that Notch signalling establishes HSC fate as their shared vascular precursors migrate across the ventral face of the somite and that junctional adhesion molecules (JAMs) mediate this required Notch signal transduction. HSC precursors express jam1a (also known as f11r) and migrate axially across the ventral somite, where Jam2a and the Notch ligands Dlc and Dld are expressed. Despite no alteration in the expression of Notch ligand or receptor genes, loss of function of jam1a led to loss of Notch signalling and loss of HSCs. Enforced activation of Notch in shared vascular precursors rescued HSCs in jam1a or jam2a deficient embryos. Together, these results indicate that Jam1a-Jam2a interactions facilitate the transduction of requisite Notch signals from the somite to the precursors of HSCs, and that these events occur well before formation of the dorsal aorta.
JAM proteins belong to the immunoglobulin superfamily of cell adhesion molecules, comprised of three closely related members, JAM1 (also known as JAM-A or F11R), JAM2 (also known as JAM-B), and JAM3 (also known as JAM-C) 5 . It has been reported that Jam1 is expressed in both murine and zebrafish HSC fractions 6, 7 , although its role in haematopoiesis remains unknown. In zebrafish, the jam1 gene was tandemly duplicated on chromosome 5 to generate jam1a and jam1b (also known as f11rl). The structure of Jam1a is similar to that of human JAM1, which is composed of two immunoglobulin-like domains, a transmembrane domain (TM), and a PDZ-binding domain (PBD), whereas Jam1b lacks the TM and PBD (Extended Data Fig. 1a-d ). We therefore focused on Jam1a to determine its potential roles in HSC development. We first examined the expression of jam1a in zebrafish embryos. At 14 h postfertilization (hpf), jam1a was expressed in bilateral stripes of posterior lateral mesoderm (PLM) (Extended Data Fig. 2a ), which gives rise to both endothelial and haematopoietic lineages 8 . After 18 hpf, however, jam1a was no longer detected in endothelial cells (Extended Data Fig. 2b, c) . We performed co-staining of jam1a with fli1, a marker of the vascular lineage. The expression domain of fli1 overlapped with that of jam1a at 14 hpf (Extended Data Fig. 2d ), indicating that PLM cells indeed express jam1a at this stage. We observed the downregulation of jam1a in purified green fluorescent protein (GFP)-labelled endothelial cells (fli1:GFP 1 cells) from 14 to 20 hpf (Extended Data Fig. 2e ).
To determine if HSC precursors are contained within jam1a 1 PLM cells, we performed lineage tracing using the combined transgenic lines, -2.2jam1a:CreER T2 , which expresses CreER T2 under the control of jam1a regulatory elements, and bactin2:loxP-BFP-loxP-DsRed, which switches from expression of blue fluorescent protein (BFP) to the DsRed red fluorescent protein following Cre-based recombination (Fig. 1a , Extended Data Fig. 2f ). Double-transgenic embryos were treated with 4-hydroxytamoxifen (4OHT) following two different schedules (Fig. 1b ). An 'early' group was treated with 4OHT from 8 hpf, a stage before PLM formation 9 , and a 'late' group from 30 hpf, a stage just before HSC emergence in the dorsal aorta 10, 11 . These embryos were grown to 3-5 months of age, after which whole kidney marrow cells were analysed by flow cytometry ( Fig. 1c ). As shown in Fig. 1d , high percentages of 'switched' DsRed 1 cells were detected in the 'early' group. DsRed 1 cells were comprised of multiple types of blood lineages (Fig. 1e ). In contrast to the 'early' schedule, DsRed 1 cells were nearly undetectable in the 'late' group ( Fig. 1d ). These results indicate that jam1a is expressed in the shared vascular precursors of HSCs during early somitogenesis stages. The expression of jam1a in HSC precursors was further confirmed by additional lineage-tracing studies using a -5.1jam1a:CreER T2 transgenic animal, which has an extended jam1a promoter/enhancer region (Extended Data Fig. 2g -l).
To examine the function of Jam1a in haematopoiesis, we designed two different morpholino oligonucleotides (MOs), jam1a MOatg (a translation-blocking MO) and MOex7 (a splice-blocking MO) (Extended Data Fig. 3a-e ). We first examined the expression of the HSC marker gene runx1 in these morphants. As shown in Fig. 1f , runx1 was detected in the dorsal aorta in uninjected wild-type embryos at 26 hpf. In contrast, runx1 was nearly undetectable in jam1a MOatg-and MOex7-injected embryos at the same stage ( Fig. 1g , h). The expression of efnb2a (ephrin-B2a, a dorsal aorta marker gene) was unaffected in either morphant ( Fig. 1i-k ), suggesting that the dorsal aorta is specified normally. To further characterize jam1a morphants, we investigated the expression of additional marker genes. The expression of cmyb (another HSC marker) in the dorsal aorta was largely absent in jam1a morphants ( Fig. 1l , m, Extended Data Fig. 3f, g) . T-cell colonization of the thymus requires input from HSCs, providing a useful readout for whether HSCs have been specified or not. In jam1a morphants, the expression of rag1 (a marker of immature T cells) was absent in the thymus at 4 days post-fertilization (dpf) ( Fig. 1n , o, Extended Data Fig. 3h , i). A truncated isoform of scl (also known as tal1), scl-b, has been shown to mark haemogenic endothelium in the dorsal aorta 12 . Comparison of scl-a/b and scl-a probes revealed the specific reduction of scl-b in the dorsal aorta in jam1a morphants ( Fig. 1p-s ). Nascent HSCs can be visualized as cmyb:GFP; kdrl:mCherry doublepositive cells in the ventral floor of the dorsal aorta 10 . The number of double-positive cells in the dorsal aorta was twelve times lower in jam1a morphants than in wild-type embryos (Extended Data Fig. 4a -c). The expression of gata1 (an erythroid marker) and l-plastin (a myeloid marker) at 24 hpf was normal in jam1a morphants, whereas the expression of l-plastin at 4 dpf was reduced in the caudal haematopoietic tissue (CHT) (Extended Data Fig. 4d-f ). These results indicate that primitive haematopoiesis is unaffected, but definitive haematopoiesis is defective in jam1a morphants. The vasculature in the trunk was normal in jam1a morphants, whereas development of the vascular plexus in the CHT was slightly abnormal (Extended Data Fig. 4g-j) . Development of the pronephros, somite, sclerotome and notochord was unaffected in jam1a morphants (Extended Data Fig. 4k-o) . These results indicate that the failure of HSC specification in jam1a morphants is specific and not due to gross malformations in adjacent environmental tissues. The effects of MOs are summarized in Supplementary Table 1 .
Since jam1a is expressed in PLM cells, we next examined the formation and migration of the PLM in jam1a morphants. The expression of fli1 at 12 hpf was normal in both types of jam1a morphants ( Fig. 2a-c) , suggesting that PLM formation is unaffected. PLM cells migrate axially and reach the midline by 17 hpf (Fig. 2d ). We observed a delay in the migration of PLM cells in both types of jam1a morphants, in that a subset of fli1 1 cells did not reach the midline by 17 hpf ( Fig. 2e , f). We performed time-lapse imaging of PLM cells from 14 hpf using fli1:GFP; phldb1:mCherry double transgenic embryos, where endothelial precursors and somitic cells are labelled by GFP and mCherry expression, respectively. PLM cells in the first wave reached the midline by 15.5 hpf in wild-type embryos, whereas the remaining cells reached the midline by 17.5 hpf to form the 'vascular cord' (Fig. 2g , Supplementary Video 1). In jam1a morphants, however, only a few PLM cells reached the midline by 15.5 hpf. Moreover, some PLM cells remained at the lateral borders of the somites at 17.5 hpf, and the vascular cord was discontinuous ( Fig. 2h , Supplementary Videos 2 and 3). We examined the morphology of migrating PLM cells. In wild-type embryos, most migrating fli1:GFP 1 PLM cells displayed a flattened morphology and appeared to interact closely with the ventral domain of the somite (Fig. 2i ). By contrast, PLM cells in jam1a morphants displayed a round shape with relatively little surface contact with the somite (Fig. 2j ).
To exclude the possibility of a general developmental delay in jam1a morphants, we enumerated somites at 14 hpf in jam1a MO control-and MOatg-injected embryos. We mainly observed nine somites formed in both jam1a MO control-and jam1a MOatg-injected embryos at this stage, and there was no significant difference in the average numbers of somites between groups (Fig. 2k, l ). This indicates that the migration defect observed in jam1a morphants is specific and not due to developmental delay. In zebrafish, Hedgehog (Hh) and Vascular endothelial growth factor a (Vegfa) signalling pathways have been implicated to regulate the migration of PLM cells 13, 14 . In jam1a morphants, however, the expression of shha (sonic hedgehog a) and vegfa as well as their downstream target efnb2a was unaffected ( Fig. 1i -k, Extended Data Fig. 4n -q), indicating that the defect of PLM cell migration in jam1a morphants is independent of the Hh and Vegfa signalling pathways.
Because PLM cells migrate along the ventral domain of the somites, which includes the sclerotome, it is likely that a binding partner of Jam1a is expressed on the somitic epithelium. Previous studies determined the expression patterns of zebrafish jam genes and their physical binding properties by surface plasmon resonance. These studies showed that Jam1a can bind to Jam2a, Jam2b and Jam3a, but not to Jam1a (homotypically), Jam1b or Jam3b. Moreover, among these 6 jam genes, only jam2a and jam3b are expressed in somites 15, 16 . Therefore, we next investigated whether PLM cells make contact with jam2a 1 somitic cells. As shown in Fig. 3a , jam2a was specifically expressed in somites at 16 hpf, a stage when PLM cells are migrating. Quantitative polymerase chain reaction (qPCR) results also showed that jam2a was highly expressed in purified alpha-actin:GFP 1 somitic cells at 14 hpf, whereas jam1a was highly expressed in purified fli1:GFP 1 PLM cells ( Fig. 3b ). Histological analysis of 16 hpf embryos revealed that migrating fli1:GFP 1 PLM cells were in close contact with jam2a 1 somitic cells ( Fig. 3c ).
To determine if Jam1a can bind to Jam2a, we performed coimmunoprecipitation experiments using transiently transfected Flag-tagged Jam1a (Jam1a-Flag) and haemagglutinin-tagged Jam2a (Jam2a-HA) constructs in HEK293T cells. Anti-Flag immunoprecipitation followed by anti-HA western blotting showed specific binding of Jam1a to Jam2a (Fig. 3d ). To further test their interaction, we used a Duolink proximity ligation assay (PLA), which can demonstrate protein-protein interactions in situ by eliciting a fluorescent signal ( Fig. 3e ). As shown in Fig. 3f , PLA signals were detected in the boundary region between transfected Jam1a-Flag 1 cells and Jam2a-HA 1 cells, revealing the interaction of these proteins in trans. These results suggest that cells of PLM maintain intimate contact with cells of the ventral somite via Jam1a-Jam2a interactions during their migration.
This model predicts that loss of jam2a function would phenocopy the effects in jam1a morphants. We thus examined both HSC specification and PLM cell migration in jam2a MOatg-or MOex5-injected embryos (Extended Data Fig. 5a-d ). The expression of runx1 in the dorsal aorta was greatly reduced in both jam2a morphants, whereas efnb2a expression was unaffected ( Fig. 3g -j, Extended Data Fig. 5e -l). In addition, axial migration of PLM cells was greatly delayed in both types of jam2a morphants ( Fig. 3k , Supplementary Videos 4 and 5), despite only a modest delay in development ( Fig. 3l ). Migrating fli1:GFP 1 PLM cells in jam2a morphants displayed a round shape (Extended Data Fig. 5m ), similar to that shown in jam1a morphants (Fig. 2j ). The average contact surface area between a PLM cell and the somite was significantly reduced in both jam1a and jam2a morphants compared with uninjected embryos (Extended Data Fig. 5n ). The effects of jam2a MOs were further validated in jam2a mutants (jam2a hu3319 ). Approximately 80% of homozygous jam2a hu3319 embryos showed nearly undetectable expression of runx1 and cmyb in the dorsal aorta and rag1 in the thymus (Extended Data Fig. 6a -g). Moreover, approximately 85% of homozygous jam2a hu3319 embryos showed delayed PLM cell migration compared with wild-type embryos (Extended Data Fig. 6h , i). Formation of the vasculature, however, was grossly normal 
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in jam2a hu3319 embryos (Extended Data Fig. 6j-o) . These phenotypes are consistent with those in jam1a morphants, suggesting that Jam1a-Jam2a interactions are involved in both PLM cell migration and HSC specification.
Despite a large reduction in embryonic HSC number, approximately 50% of homozygous jam2a hu3319 animals were viable and showed almost normal haematopoiesis in the adult kidney (Extended Data Fig. 6p, q) . Further studies will be required to understand how haematopoiesis can recover in jam2a hu3319 animals during development. Perhaps related to this observation, a dispensable role for Jam2 in adult haematopoiesis has also been reported in mice 17, 18 .
To better understand how both jam1a and jam2a morphants show impaired HSC specification, we considered possible signal transduction mechanisms from the somite. Because our recent work demonstrated that two somitic Notch ligands, Dlc and Dld, are essential for HSC specification 4 , and because Notch is a juxtacrine signal that requires close contact between adjacent cells, we prioritized analysis of the Notch signalling pathway. To test the hypothesis that Jam1a-Jam2a interactions facilitate Notch signal transmission between the PLM and somite, we first examined the activation of Notch signalling in jam1a morphants using a Notch reporter line, Tp1:GFP, which expresses GFP under the control of tandem Notch responsive elements 19 . In wild-type embryos, some fli1:DsRed 1 endothelial cells strongly expressed Tp1:GFP in the midline at 18 hpf (Fig. 4a) . In jam1a morphants, by contrast, most of the fli1:DsRed 1 cells showed weak or no expression of the Tp1:GFP reporter at the same stage (Fig. 4b) . The expression levels of Tp1:GFP in fli1:DsRed 1 cells were further quantified by flow cytometry (Fig. 4c) . The mean fluorescence intensity of GFP in the Tp1:GFP 1 ; fli1:DsRed 1 population was significantly lower in jam1a morphants than in uninjected embryos (Fig. 4d) . In wild-type embryos, runx1 is highly expressed in the Tp1:GFP high fraction of fli1:DsRed 1 cells at 22 hpf (Fig. 4e) , suggesting that HSC precursors are enriched in this population. Notably, the percentage of Tp1:GFP high ; fli1:DsRed 1 cells was significantly lower in jam1a morphants (Fig. 4f ). At 28 hpf, Tp1:GFP was highly expressed in the dorsal aorta in wild-type embryos (Fig. 4g, h) . Interestingly, in jam1a morphants, Tp1:GFP expression was weak and discontinuous along the floor of the dorsal aorta ( Fig. 4i, j) , the site of HSC emergence 10, 11 . In addition, we observed many apoptotic cells along the aortic floor in jam1a morphants (Fig. 4k, l ), suggesting that, in the absence of Notch signalling, HSC precursors fail to be specified and undergo apoptosis.
To test whether ectopic activation of Notch signalling is sufficient to rescue HSCs in jam1a morphants, we enforced expression of the Notch intracellular domain (NICD), a dominant activator of the Notch pathway 3 , using combined hsp70:Gal4; UAS:NICD transgenic lines. Heat-shock 
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induction of NICD at 14 hpf rescued the expression of runx1 in the dorsal aorta in jam1a morphants (Extended Data Fig. 7a, b ), similar to that shown previously for rescue of mind bomb (mib) mutants or wnt16 morphants 3, 4 . The expression of runx1 was also rescued in jam1a morphants when NICD was induced in the PLM using the fli1:Gal4 line (Extended Data Fig. 7c, d) . Similar results were obtained in jam2a MOatg-injected embryos (Extended Data Fig. 7e, f) . At 15 hpf, migrating fli1:GFP 1 cells were observed to make direct contact with dlc 1 or dld 1 somitic cells (Extended Data Fig. 8a, b) , indicating that PLM cells may receive Notch signalling via presentation of somitic Notch ligands. We observed low activation of Tp1:GFP in endothelial cells in wnt16 morphants (Extended Data Fig. 8c-g) , which show a reduction in somitic dlc and dld 4 . This suggests that Notch signalling in endothelial cells is activated at least in part by somitic Dlc and/or Dld. We investigated the expression of somitic Notch ligand genes (dlc and dld) as well as aortic Notch receptor and ligand genes (notch1a, notch1b, notch3, dlc and delta-like 4 (dll4)) in jam1a morphants. Importantly, each was expressed normally in jam1a morphants ( Fig. 4m-q , Extended Data Fig. 9a-h) , suggesting that the defect in Notch signalling in jam1a morphants is due to low Notch signal transmission rather than to misregulation of Notch signalling components. Consistent with this postulate, we observed less contact surface area between migrating PLM cells and the somite in both jam1a and jam2a morphants ( Fig. 2i , j, Extended Data Fig. 5m, n) , which correlates with low activation of Notch signalling. Our hypothesis is further supported by an additional rescue experiment in which dlc or dld is globally overexpressed in jam1a morphants to present more Notch ligand to HSC precursors. As presented in Fig. 4u , the expression of runx1 in the dorsal aorta was almost fully rescued by co-injection of dld messenger RNA (mRNA) along with the jam1a MOatg, whereas runx1 expression was only partially rescued following co-injection with dlc mRNA (Fig. 4r-u) . Furthermore, the expression of Tp1:GFP was also restored in the ventral floor of the dorsal aorta by co-injection with dlc or dld mRNA (Extended Data Fig. 9i-p) . These data confirm that the impairment of HSC specification in jam1a morphants is caused by inadequate activation of Notch signalling in HSC precursors and suggest that Jam1a and Jam2a normally mediate the physical interaction between these precursors and the somite, which is required for efficient Notch signal transmission (Extended Data Fig. 10 ).
It has been reported that the overall levels of Notch signal transmission is proportional to adhesion strength between Notch receptor-and ligand-expressing cells 20 . Our data demonstrate that runx1 is highly expressed in the Tp1:GFP high population of endothelial cells (Fig. 4e ), suggesting that a relatively high level of Notch signalling is required to generate HSC fate. These findings strongly suggest that efficient Notch signal transduction in HSC precursors requires intimate intercellular contact mediated by Jam proteins. Moreover, our data suggest that HSC fate is established much earlier than previously appreciated, during the axial migration of PLM cells, which is well before formation of the dorsal aorta. These new findings may provide key insights into the timing and tissue interactions needed to instruct HSC fate, which should help inform in vitro approaches to generate HSCs from pluripotent stem cells.
METHODS SUMMARY
For morpholino knockdown experiments, zygotes were injected with 1 nl of morpholino oligonucleotides (MOs, GeneTools). MO concentrations used were: jam1a MOatg (100 mM), jam1a MO control (100 mM), jam1a MOex7 (300 mM), jam2a MOatg (300 mM), jam2a MOex5 (400 mM), and wnt16 MO2 (5 ng nl 21 ). Fluorescent images were captured using an SP5 inverted confocal microscope (Leica) as previously described 10 . Flow cytometry, qPCR, in situ hybridization, histology, Duolink PLA, immunoprecipitation, and western blotting were performed as described in the Methods section.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Zebrafish husbandry and heat shock. Zebrafish were maintained as previously described 21 Alignment and phylogenetic analysis. cDNA and amino acid sequences were obtained from the National Center for Biotechnology Information (NCBI) database (http://www.ncbi.nlm.nih.gov/). The deduced amino acid sequences of zebrafish Jam1a, Jam1b, and human JAM1 were aligned using ClustalW (European Bioinformatics Institute). A phylogenetic tree of JAM subfamily proteins was constructed as previously described 29 . Protein domains were predicted using the SMART database (http://smart.embl-heidelberg.de/). The gene locations for zebrafish jam1a and jam1b were examined using the genomic sequence database version 9 at Sanger (http://www.sanger.ac.uk/). Generation of transgenic lines. Tg(-2.2jam1a:GFP) sd25 : a 2.2-kb fragment immediately upstream of the jam1a transcriptional start site was cloned from zebrafish genomic DNA and ligated upstream of the EGFP site in I-SceI-pBSII SK1. Vectors were flanked by I-SceI sites and injected into one-cell stage embryos with I-SceI (Roche, 11362399001) to generate transgenic founders. Three -2.2jam1a:GFP founders were identified by screening for the GFP fluorescence of progeny. The line used in this study showed the strongest GFP expression. Tg(-2.2jam1a:CreER T2 ; -2.2jam1a: GFP) sd26 : The CreER T2 fragment was amplified by PCR from pCAG-CreER T2 (Addgene) and ligated upstream of the jam1a promoter in the jam1a:GFP vector. Then, an additional jam1a promoter was ligated upstream of the CreER T2 . Ten -2.2jam1a:CreER T2 ; -2.2jam1a:GFP founders were identified by screening for the GFP fluorescence of progeny. Tg(-5.1jam1a:CreER T2 ; -5.1jam1a:GFP) sd34 : a further 2.9-kb fragment cloned from zebrafish genomic DNA was ligated upstream of both the 2.2-kb promoters (total 5.1 kb). Three -5.1jam1a:CreER T2 ; -5.1jam1a:GFP founders were identified by screening for the GFP fluorescence of progeny. Tg(bactin2:loxP-BFP-loxP-DsRed) sd27 : A PCR-amplified DsRed Express fragment was used to replace the EGFP site in the pIST2-Myl2-loxP-TagBFP-loxP-EGFP vector. The loxP-TagBFP-loxP-DsRed Express site was then used to replace the EGFP site in the I-SceI-pBSII SK1 vector. A 10.8-kb fragment immediately upstream of the bactin2 transcriptional start site was cloned from zebrafish genomic DNA and ligated upstream of the loxP-TagBFP-loxP-DsRed Express site. Four bactin2:loxP-BFP-loxP-DsRed founders were identified by screening for the BFP fluorescence of progeny. Cell preparation and flow cytometry. Kidney marrow cells were prepared as previously described 29 . Briefly, kidneys were dissected, and haematopoietic cells were obtained by macerating the kidney on a stainless steel mesh in 5 ml of ice-cold 2% fetal bovine serum (FBS) in Hanks' balanced salt solution (HBSS). After centrifugation, the pellet was gently mixed with 1 ml of distilled water by pipetting to lyse erythrocytes by osmotic shock. Subsequently, 1 ml of 23 HBSS was added, and the cells were washed with HBSS by centrifugation. Cells from embryos were prepared as previously described 10 . Briefly, embryos were collected and anesthetized in E3 medium containing 0.01% tricaine, and were digested with Liberase TM (Roche, 05401119001) in PBS for 1 h at 37 uC. Cells were then filtered through 40-mm nylon mesh and washed with 2% FBS in HBSS by centrifugation. Just before flow cytometric analysis, Sytox Red (Invitrogen, S34859) solution was added to the samples at a final concentration of 5 nM to exclude nonviable cells. Flow cytometric acquisition was performed on a BD LSR Fortessa (BD Biosciences), and cell sorting was performed on a FACS Aria II (BD Biosciences). Analysis was performed using FlowJo software (Treestar). Cells were sorted into 20% FBS in HBSS, and were used for morphological or expression analysis. qPCR and RT-PCR. Total RNA was extracted from embryos, dissected kidneys, or sorted cells using RNeasy Mini Kit (QIAGEN, 74104), and cDNAs were synthesized using QuantiTect Reverse Transcription Kit (QIAGEN, 205311). Quantitative real-time PCR (qPCR) assays were performed on a BIO-RAD CFX96 real time system according to the manufacturer's instructions (BIO-RAD). The expression of ef1a was used to normalize the amount of the investigated transcripts. Reverse transcription (RT)-PCR was performed as previously described 7 . Primers used in qPCR and RT-PCR are listed in Supplementary Table 2 . In situ hybridization. cDNAs were cloned by RT-PCR using specific primers listed in Supplementary Table 2 , and ligated into the pCRII-TOPO vector (Invitrogen, K4620-01). Digoxigenin (DIG)-or fluorescein-labelled RNA probes were prepared by in vitro transcription with linearized constructs as previously described 29 . Embryos were fixed with 4% paraformaldehyde (PFA) in PBS at 4 uC overnight. Whole-mount in situ hybridization (WISH) was performed as previously described 30 . Two-colour WISH was performed using DIG-and fluorescein-labelled probes.
Embryos were developed with nitro blue tetrazolium chloride (NBT, Roche, 11383213001)/5-bromo-4-chloro-3-indolyl phosphate, toluidine salt (BCIP, Roche, 11383221001) and FastRed (Roche, 11496549001). Two-colour stained embryos were photographed after removal of the yolk extension tube. Immunohistochemistry and haematoxylin and eosin staining. Embryos were fixed with 4% PFA, embedded in paraffin, and sectioned at 4 mm in thickness. Deparaffinized tissue sections were incubated with blocking solution (1% goat serum, 1% donkey serum, and 0.2% bovine serum albumin in PBS) for 30 min at room temperature and then incubated with 1:1,000 chicken anti-GFP (Aves, GFP-1020), 1:1,000 rabbit anti-RFP antibodies (for DsRed staining, Abcam, ab34771), and/or 1:500 mouse anti-mCherry antibodies (Abcam, ab125096) overnight at 4 uC. For fluorescent immunohistochemistry, sections were incubated with 1:1,000 goat anti-chicken IgG Alexa Fluor 488-conjugated (Molecular Probes, A-11039), 1:1,000 donkey antirabbit IgG Alexa Fluor 594-conjugated (Molecular Probes, A-21207), and/or goat anti-mouse IgG Alexa Fluor 594-conjugated (Molecular Probes, A-11005) secondary antibodies for 1 h at room temperature. After washing, sections were mounted with Duolink in situ mounting medium with DAPI (Olink, DUO82040). For colorimetric immunohistochemistry, sections were stained with anti-GFP antibody, followed by staining with 1:1,000 anti-chicken IgG horseradish peroxidase (HRP)conjugated secondary antibody (invitrogen, 61-3120) for 1 h at room temperature. Sections were then developed with 3, 39-diaminobenzidine (DAB) substrate solution (Sigma, D5905) for 3 min at room temperature. After washing, sections were mounted with mounting medium (50% glycerol, 10% gelatin in double-distilled H 2 O). Wholemount immunofluorescence was performed as described 4 , using 1:500 mouse anti-cMyc antibody (Sigma, M4439) and 1:1,000 donkey anti-mouse IgG Alexa Fluor 488-conjugated (Molecular Probes, A-21202). Haematoxylin and eosin staining was performed on deparaffinized tissue sections as previously described 29 . Transient expression. A Flag and HA tag were inserted between the two Ig domains of jam1a and jam2a by two-step PCR, respectively, and cloned into the pcDNA3 vector as previously described 29 . HEK293T or HeLa cells were transiently transfected with the above constructs using FuGENE HD transfection regent (Promega, E2311). Cells were then cultured in six-well plate with 10%FBS, 200 mM L-glutamine in Dulbecco's modified Eagle medium (DMEM) at 37 uC and 5% CO 2 . Immunoprecipitation and western blotting. HEK293T cells expressing Jam1a-Flag and/or Jam2a-HA constructs were harvested and lysed in lysis buffer (25 mM Tris-HCl pH 7.4, 1 mM EDTA, 0.1 mM EGTA, 150 mM NaCl, 5 mM MgCl 2 , 2 mM Na 3 VO 4 , 20% glycerol, 0.1% Triton X-100, 1 mM dithiothreitol, proteinase inhibitor). Samples were then centrifuged to remove precipitated proteins and were incubated with anti-Flag M2 agarose antibody (Sigma, A2220) for 3 h at 4 uC. Samples were washed three times with lysis buffer, resuspended in 23 sample buffer (4% SDS, 0.2 M dithiothreitol, 0.1 M Tris-HCl pH 6.8, 10% glycerol, 20 mg ml 21 bromophenol blue), and boiled for loading. Western blotting was performed as previously described 31 . Briefly, samples were separated by a NuPAGE 4-12% Bis-Tris Gel (Novax, NP0335BOX). The gel was then transferred using Semi-Dry transfer cell (BIO-RAD) to Immobilon-P Membrane (Millipore, IPVH00010). The membrane was blocked with 1% skim milk, 0.05% Tween-20 in PBS for 30 min at room temperature, and then incubated with 1:1,000 mouse anti-HA antibody (Covance, MMS-101P) or 1:1,000 rabbit anti-Flag antibody (Sigma, F7425) overnight at 4 uC. After washing with 0.05% Tween-20 in PBS (PBST), the membrane was incubated with 1:10,000 goat anti-mouse IgG HRP-conjugated secondary antibody (Jackson ImmunoResearch, 115-035-166) or 1:10,000 goat anti-rabbit IgG HRP-conjugated secondary antibody (Jackson ImmunoResearch, 111-035-144) for 45 min at room temperature. After washing with PBST, chemiluminescence was performed using the SuperSignal West Pico Chemiluminescent Substrate (Thermo, 34077). Duolink proximity ligation assay. Hela cells expressing Jam1a-Flag or Jam2a-HA construct were co-cultured on a cover slip. Cells were fixed with 4% PFA for 20 min at room temperature, blocked with 0.1% gelatin-PBS, and stained with 1:1,000 rabbit anti-Flag and 1:1,000 mouse anti-HA antibodies for 40 min at room temperature. After washing with 0.1% gelatin-PBS, proximity ligation assay (PLA) was done according to manufacturer's protocol (Olink). Cells were then stained with 1:1,000 donkey anti-mouse IgG Alexa Fluor 488-conjugated and 1:1,000 goat anti-rabbit IgG Alexa Fluor 647-conjugated (Molecular Probes, A-21244) secondary antibodies for 40 min at room temperature. After washing with 0.1% gelatin-PBS, cells were mounted with Duolink in situ mounting medium with DAPI. Microscopy and acridine orange staining. Fluorescent images were captured using an SP5 inverted confocal microscope (Leica) as previously described 10 . For time-lapse imaging, embryos were embedded in agarose (1.0% in E3 medium) containing tricaine at a temperature of 28.5 uC. z-stacks were taken every 196 s. Videos were created following processing with Volocity software (Improvision). Acridine orange staining was performed as previously described 32 . Briefly, embryos were dechorionated and incubated in 13 E3 medium containing 5 mg ml 21 acridine orange (Sigma, A8097) for 30 min, followed by three washes in 13 E3. Embryos were then visualized by confocal microscopy. All images captured by confocal microscopy
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were displayed as maximum projections. Visible light imaging was performed on a BX-51 microscope using 1003 oil objective lens and DP70 digital camera and software (Olympus) or a Leica MZ16 microscope and DFC295 digital camera and software (Leica). Morpholino and mRNA injection. Embryos were injected at the one-cell stage with 1 nl of morpholino oligonucleotides (MOs, GeneTools) and/or mRNA. The MO sequences and concentrations used in this study are as follows: jam1a MOatg, AGCACACAAAGGCGAAGGTCAACAT (100 mM); jam1a MO control, AGgAg ACAAAcGCcAAGcTCAACAT (100 mM, lowercase letters denote mismatched bases); jam1a MOex7, ATCACCTTTAACAGAGAACAACACA (300 mM); jam2a MOex5, AGGAACTACAGCAGAAACAGGTCAA (400 mM). The jam2a MOatg (300 mM) 15 and wnt16 MO2 (5ng/nl) 4 were used as previously reported. The effects of MOs are summarized in Supplementary Table 1 . Capped mRNAs were synthesized from linearized pCS21 constructs using the mMessage mMachine SP6 kit (Ambion, AM1340), and were injected into embryos at following concentrations; dlc, 50 ng ml 21 ; dld, 50 ng ml 21 . 4OHT treatment. 4-hydroxytamoxifen (4OHT, Sigma, H7904) was dissolved in ethanol as a 25 mM stock solution. Embryos were incubated with 5 mM of 4OHT in E3 medium. Control embryos were incubated in E3 medium containing 0.02% ethanol. After treatment, the embryos were washed twice in E3 medium and grown as described above. Experimental design and statistics. All experiments comparing treatment groups were made using randomly assigned siblings without investigator blinding. Sample sizes were chosen after estimating effect size, and data were analysed for statistical significance after at least two repeated experiments. All data were analysed by comparison of means using unpaired two-tailed Student's t-tests. No data were excluded. A value of P , 0.01 was considered to be statistically significant. 
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